A versatile in vitro ELISA test for quantification and quality testing of infectious, inactivated and formulated rabies virus used in veterinary monovalent or combination vaccine

作者: Cécile Sigoillot-Claude , Myriam Battaglio , Marc Fiorucci , Delphine Gillet , Anne-Sophie Vimort

DOI: 10.1016/J.VACCINE.2015.06.091

关键词:

摘要: Regulatory potency test for rabies vaccines requires mice vaccination followed by challenge with a live virus via intracerebral route. An alternative in vitro test, consistent the “3R's” (Reduce, Replace, Refine) was designed to quantify active glycoprotein G using seroneutralizing monoclonal antibodies. This versatile ELISA targets well conformed neutralizing epitopes. Therefore, it quantifies only trimeric pre-fusion form of known elicits production viral The makes possible antigen during all steps product cycle (i.e. cultivation, downstream process, formulation and stability presence aluminum gel or other vaccine valence). Moreover, batch-to-batch consistency our ingredients formulated products could be demonstrated.

参考文章(33)
Daas A, Milne C, Establishment of batch 4 of the Biological Reference Preparation (BRP) for rabies vaccine (inactivated) for veterinary use. Pharmeuropa bio / the Biological Standardisation Programme, EDQM. ,vol. 2004, pp. 17- 22 ,(2004)
Tadeusz J. Wiktor, Hilary Koprowski, Antigenic Properties of Rabies Virus Components Journal of Immunology. ,vol. 110, pp. 269- 276 ,(1973)
C Prehaud, P Coulon, F LaFay, C Thiers, A Flamand, Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence. Journal of Virology. ,vol. 62, pp. 1- 7 ,(1988) , 10.1128/JVI.62.1.1-7.1988
A Benmansour, H Leblois, P Coulon, C Tuffereau, Y Gaudin, A Flamand, F Lafay, Antigenicity of rabies virus glycoprotein. Journal of Virology. ,vol. 65, pp. 4198- 4203 ,(1991) , 10.1128/JVI.65.8.4198-4203.1991
Richard Gibert, Monique Alberti, Bertrand Poirier, Corinne Jallet, Noël Tordo, Sylvie Morgeaux, A relevant in vitro ELISA test in alternative to the in vivo NIH test for human rabies vaccine batch release. Vaccine. ,vol. 31, pp. 6022- 6029 ,(2013) , 10.1016/J.VACCINE.2013.10.019
K. Gamoh, M. Senda, O. Itoh, M. Muramatsu, N. Hirayama, R. Koike, Y.S. Endoh, N. Minamoto, Use of ELISA forin vitroPotency Test of Rabies Vaccines for Animal Use Biologicals. ,vol. 24, pp. 95- 101 ,(1996) , 10.1006/BIOL.1996.0012
Wlamir Corrêa de Moura, Humberto Pinheiro de Araujo, Pedro Hernan Cabello, Phyllis Catharina Romijn, José Paulo Gagliardi Leite, Potency evaluation of rabies vaccine for human use: the impact of the reduction in the number of animals per dilution. Journal of Virological Methods. ,vol. 158, pp. 84- 92 ,(2009) , 10.1016/J.JVIROMET.2009.01.017
Gontu Abhinay, Scott Dessain, Adabala Srikanth, RL Senthilkumar, Pitta Vidyasagar, Alagangula Praveen, RV Chandrasekhar Reddy, Erri Swapna Reddy, Lingala Rajendra, None, A novel site-II directed glycoprotein estimation ELISA to aid rabies vaccine manufacture for veterinary and human use Vaccine. ,vol. 32, pp. 209- 213 ,(2014) , 10.1016/J.VACCINE.2013.11.026